Low-Dose Valganciclovir for Primary Cytomegalovirus Prophylaxis After Heart Transplant: A 10-Year Experience. Concannon K, Page R, Swayngim R, Ambardekar AV, et al. Clin Transplant 2025;39:e70408.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Concannon K, Page R, Swayngim R, Ambardekar AV, et al. Low-Dose Valganciclovir for Primary Cytomegalovirus Prophylaxis After Heart Transplant: A 10-Year Experience. Clin Transplant 2025;39:e70408.
PMID: 41369514